BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial …
Over the last 12 months, insiders at BioSig Technologies, Inc. have bought $0 and sold $0 worth of BioSig Technologies, Inc. stock.
On average, over the past 5 years, insiders at BioSig Technologies, Inc. have bought $268,466 and sold $530,371 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 15,600 shares for transaction amount of $19,358 was made by LONDONER KENNETH L (Chief Executive Officer) on 2023‑06‑13.
2023-06-13 | Chief Executive Officer | 15,600 0.025% | $1.24 | $19,358 | -54.68% | |||
2023-06-12 | Chief Executive Officer | 6,000 0.0094% | $1.17 | $7,040 | -53.03% | |||
2023-06-02 | Chief Executive Officer | 4,600 0.0078% | $1.37 | $6,292 | -56.10% | |||
2023-05-31 | Chief Executive Officer | 8,000 0.0132% | $1.57 | $12,560 | -62.18% | |||
2023-02-08 | Chief Financial Officer | 232,882 0.0003% | $0.86 | $199,999 | -31.84% | |||
2022-09-07 | Chief Executive Officer | 1,000 0.0022% | $0.83 | $830 | +5.37% | |||
2022-09-02 | Chief Executive Officer | 1,000 0.002% | $1.00 | $1,000 | -19.72% | |||
2022-09-01 | Chief Executive Officer | 17,240 0.0368% | $1.08 | $18,704 | -22.35% | |||
2022-09-01 | Chief Financial Officer | 11,425 0.0254% | $1.13 | $12,929 | -22.35% | |||
2022-08-30 | Chief Operating Officer | 5,000 0.0113% | $1.07 | $5,335 | -16.19% | |||
2022-08-29 | Chief Executive Officer | 6,100 0.0137% | $1.10 | $6,710 | -19.13% | |||
2022-08-25 | Chief Executive Officer | 1,000 0.0022% | $1.12 | $1,120 | -23.08% | |||
2022-08-24 | 17,000 0.0391% | $1.16 | $19,720 | -20.96% | ||||
2022-08-24 | Chief Operating Officer | 10,000 0.0225% | $1.13 | $11,347 | -20.96% | |||
2022-08-24 | Chief Commercial Officer | 36,036 0.0843% | $1.18 | $42,522 | -20.96% | |||
2022-08-23 | Chief Executive Officer | 2,000 0.0046% | $1.10 | $2,200 | -16.90% | |||
2022-08-22 | Chief Financial Officer | 8,000 0.0175% | $1.13 | $9,016 | -20.83% | |||
2022-08-19 | Chief Executive Officer | 4,000 0.0085% | $1.00 | $4,000 | -11.13% | |||
2022-08-17 | Chief Executive Officer | 6,000 0.0137% | $0.99 | $5,940 | -1.19% | |||
2022-08-16 | Chief Executive Officer | 4,100 0.0088% | $0.96 | $3,936 | -2.58% |
LONDONER KENNETH L | Chief Executive Officer | 2507020 14.5462% | $1.48 | 108 | 75 | +0.43% |
CHAUSSY STEVE | Chief Financial Officer | 1051553 6.1013% | $1.48 | 23 | 0 | +14.3% |
FOLEY DONALD E | director | 255000 1.4796% | $1.48 | 2 | 0 | +9.74% |
BUHALY STEVEN J | Chief Financial Officer | 232882 1.3512% | $1.48 | 1 | 0 | <0.0001% |
ODONNELL JEFFREY F | director | 151629 0.8798% | $1.48 | 1 | 2 | <0.0001% |
The Vanguard Group | $45,469.00 | 0.49 | 68,788 | -97.11% | -$1.53M | <0.0001 | |
BlackRock | $40,046.00 | 0.43 | 60,584 | -90.06% | -$362,853.09 | <0.0001 | |
Geode Capital Management | $37,529.00 | 0.4 | 56,762 | -89.97% | -$336,806.28 | <0.0001 | |
Jane Street Capital | $28,962.00 | 0.31 | 43,815 | +148.89% | +$17,325.64 | <0.0001 | |
Hrt Financial Llc | $17,000.00 | 0.19 | 26,331 | New | +$17,000.00 | <0.0001 |